In order to ensure that you continue to receive information that is of interest from PharmaVentures help us by subscribing. Thank you for your co-operation. Free of charge listing in the Product and Service Locator section of the Drug Delivery Companies report Don't miss out on the opportunity to profile your company in the Product and Service Locator section of the new Autumn/Winter 2005 Drug Delivery Companies report. The product and service locator table provides a comprehensive reference chart profiling companies' products and services in the drug delivery industry, and is used by executives who are actively assessing drug delivery opportunities. Submit your Product and Service Locator profile by 31st August to make sure you are featured in the next issue of the Drug Delivery Companies report. Market News and Trends During July 2005 PharmaDeals® Agreements recorded 18 deals that relate to drug delivery. Within these announcements there are two deals that relate to combining drug delivery technologies with medical devices, and concern the development of improved stents. The first deal, announced on 12th July, was between SurModics, Inc. and CardioMind, Inc. Later in the month, on 25th July, MediaVas LLC and Picarus NV announced that they had signed a similar agreement. Read more... Featured Article Current Trends in Liposomal Drug Delivery Systems Since the early 1970s it has been recognised that liposomes have significant potential as carriers for therapeutic agents. Extensive investment has been made into the research and development of liposome delivery systems for a wide range of applications, including chemotherapeutics, genetic material, vaccines, therapeutic proteins and anti-inflammatory agents. Dr Clive Prestidge et al., Ian Wark Research Institute, Australia, examine the recent developments in this field. Read more... Company Profiles Biocompatibles, Phogen, pSiMedica, Themis Drug Delivery Opportunities View all our Drug Delivery Opportunities or alternatively request a password to submit your opportunity online. Featured Opportunity Formulation Technology for Buccal Spray Delivery of Large Molecules Administrative route - Other Indication - Multiple indications, anxiety, etc. Licence code LO-0705-09 Promote your company in the Drug Delivery Companies report - Autumn/Winter 2005 The Drug Delivery Companies report is distributed to over 8000+ key decision makers and is relied upon within the industry as the main method of independently assessing drug delivery partners. Established for over 10 years, this biannual report provides drug delivery companies with access to senior deal making decision makers within the pharmaceutical and biotechnology companies and is the main publication of choice for anyone wishing to complete a deal. Find out more about promoting your company.
Drug Delivery E-News is produced by PharmaVentures Intelligence, part of PharmaVentures - a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making. Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence, we work with clients to drive greater value from their deals. If you do not wish to receive DDR E-News in future, please e-mail ddcr@pharmamail.biz with the words UNSUBSCRIBE as the subject. If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddcr@pharmamail.biz with REMOVE as the subject. For more details contact Mel Hemamda, Product Manager, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail enquiries@ddcr.com www.ddcr.com